PRESS RELEASE
News
-
-
PRESS RELEASE
Splash Beverage Group's Copa di Vino Now Available in Save Mart Stores Throughout California
Splash Beverage Group, Inc. announced that its Copa Di Vino and Pulpoloco Sangria will now be available in 200 Save Mart Stores located in Central and Northern California. The planogram positions for these products have already been provided, with on-shelf availability starting in February. This expansion is part of Splash Beverage Group's strategy to rapidly develop and accelerate its brand portfolio and global distribution. For more information, visit www.SplashBeverageGroup.com. -
PRESS RELEASE
KYN Capital Group Releases New Version of Koinfold 2.0 on Google Play Store and Submits the Apple IOS Version for Release
KYN Capital Group has released a new version of Koinfold 2.0 on the Google Play Store and has submitted the Apple IOS version for release. The updated version includes new features such as cryptocurrency swap options, email verification for security, and 24/7 cryptocurrency news. Koinfold 2.0 also offers the ability to mine crypto through Cudominer and a user-friendly design. The 'Learn to Earn' feature allows users to test the market with $10,000 in play cryptocurrency, providing a safe and easy way to learn. The app will soon implement a precious metal feature, which is expected to generate substantial revenue for KYN Capital Group. CEO Rick Wilson expressed optimism about the alignment of Koinfold with the crypto movement and its potential to generate significant revenue. For more information, follow KYN Capital Group, Inc. (KYNC) on Twitter and visit their website. -
PRESS RELEASE
Dog Study Published in PLOS ONE Shows Statistically Significant Results for Use of Jaguar Health’s Crofelemer for Preventive Treatment of Cancer Therapy-Related Diarrhea (CTD)
Jaguar Health, Inc. (NASDAQ:JAGX) has announced the publication of a study evaluating the effects of crofelemer in providing symptomatic relief of diarrhea associated with the irreversible pan-human epidermal growth factor receptor (HER) tyrosine kinase inhibitor neratinib (Nerlynx®) in female dogs. The study, conducted by Napo Pharmaceuticals in collaboration with Puma Biotechnology, highlights the growing need for treatment of cancer therapy-related diarrhea (CTD), a common and debilitating side effect of patients undergoing cancer therapy. The findings of this study, along with two other important studies, provide scientific rationale for the use of crofelemer in humans for the prevention and treatment of CTD, addressing the unmet medical need in the age of targeted cancer therapies. -
PRESS RELEASE
Revolutionizing NDT Inspection: Voliro's Innovative Technology Eliminates Downtime
Voliro introduces the high-temperature Ultrasonic Testing (UT) payload for the Voliro T drone, revolutionizing the Non-Destructive Testing (NDT) sector by enabling inspections on hot surfaces without costly downtime. This groundbreaking technology offers a safer, more efficient, and cost-effective approach to inspections in challenging industrial environments. -
PRESS RELEASE
FAVO Capital, Inc. Opens A Second Call Centre Location in Dominican Republic and Continues to Implement its Growth Strategy
FAVO Capital Inc., a respected alternate finance company, is expanding its reach with the opening of a new call centre location in the Dominican Republic. This strategic move showcases its commitment to providing exceptional financial solutions and services, offering innovative products, and investing in technology and talent to meet the needs of its clientele. The company is also dedicated to community engagement, aiming to make a positive impact beyond financial services. With this expansion, FAVO Capital reinforces its position as a leader in the industry and invites clients, partners, and the media to stay updated on their journey towards innovation and excellence. -
PRESS RELEASE
CMI Investor Alert: Kaplan Fox Investigates Potential Securities Fraud At Cummins, Inc.
Kaplan Fox & Kilsheimer LLP is conducting an investigation into potential securities fraud at Cummins Inc. following the announcement of a $1.675 billion penalty to settle claims of violating the Clean Air Act. If you are an investor of Cummins Inc. and would like to discuss the investigation, contact Kaplan Fox for more information. With over 50 years of experience in securities litigation, Kaplan Fox is a leading national law firm with a track record of successfully shaping the law through winning important decisions on behalf of clients. -
PRESS RELEASE
Louisiana, USA: Cloud-based deployment of Kapsch’s Commercial Back Office System and End-to-End tolling solution enters full operation
Kapsch TrafficCom successfully deploys a cloud-based Commercial Back Office System and End-to-End tolling solution in Louisiana, USA. The LA1 tolling facility, serving as a crucial transportation artery for the state and country, has been revamped with state-of-the-art toll collection and enhanced customer service capabilities. -
PRESS RELEASE
BioAdaptives' Subsidiary, Livestock Impact, Inc., Celebrates Banner 2023 Equine Championship Titles Attributed to Its Advanced Proprietary Supplement Products
BioAdaptives Inc. celebrates the achievement of multiple Equine Championship Titles attributed to its subsidiary Livestock Impact, Inc.'s advanced proprietary supplements. The highlight was the spectacular performance of Cheyanne Colclasure with her 23-year-old horse, Docs Dual Quixote, who secured the 35,000 Non Pro National Championship Title at the 2023 United States Cutting Horse Association (USCHA) National Championship competition. Livestock Impact's All-In-One supplement formulas have shown rejuvenating effects such as improved energy, agility, and response time in animals. BioAdaptives, Inc. manufactures and distributes natural plant- and algal-based products that improve health and wellness for humans and animals, with an emphasis on pain relief, antiviral activity, immune system defense, resistance to stress, endurance, recovery, and anti-aging properties. The company's products for horses and dogs provide general health, competitive performance enhancement, rejuvenation effects, and pain relief, as well as improvements in appearance. -
PRESS RELEASE
Balto Releases QA Copilot, Superhuman Levels of Accuracy and Consistency
Balto unveils the latest leap forward in QA automation for contact centers with Balto QA Copilot. This new generative AI tool allows users to auto-score calls based on natural language criteria, revolutionizing traditional QA methods. Balto QA Copilot redefines the future of quality assurance in contact centers, enabling teams to focus on meaningful interactions rather than tedious scoring. Learn more about Balto QA Copilot in an educational webinar on January 25th.
